Consultant Endocrinologist, Metabolic Medicine – Dubai

Allocation Assist Middle East; Dubai; On-site; AED 65,000 - 85,000; Full time

Job summary

Allocation Assist Middle East seeks an experienced Consultant Endocrinologist - Metabolic Medicine in Dubai to lead comprehensive endocrine and metabolic care. You will diagnose and manage diabetes, thyroid, adrenal, and pituitary disorders, and oversee osteoporosis and obesity treatments across inpatient and outpatient settings.

The role emphasizes advanced diabetes technology, insulin management, CGM interpretation, and multidisciplinary coordination to improve long-term outcomes for complex

Qualifications

• Medical degree and board-certified endocrinology training.
• Extensive experience in endocrine and metabolic medicine.
• Proven ability to manage complex diabetes and endocrine disorders.

Responsibilities

• Provide consultant-level assessment and management of endocrine and metabolic disorders.
• Lead diagnosis and treatment of diabetes mellitus (Type 1 and Type 2).
• Develop individualized diabetes treatment plans including insulin therapy.
• Interpret CGM data and optimize glucose management.
• Coordinate thyroid, adrenal, and pituitary evaluation and therapy.
• Oversee osteoporosis and metabolic bone disease management.
• Educate patients on lifestyle, medications, and disease prevention.
• Collaborate with multidisciplinary teams for comprehensive care.

Skills

Endocrinology

Metabolic medicine

Diabetes management

Insulin therapy

CGM systems

Education

Medical degree

Postgraduate training internal medicine

Board certification in endocrinology

Tools

CGM platforms

Thyroid imaging protocols

Job description

Allocation Assist Middle East seeks an experienced Consultant Endocrinologist - Metabolic Medicine in Dubai to lead comprehensive endocrine and metabolic care. You will diagnose and manage diabetes, thyroid, adrenal, and pituitary disorders, and oversee osteoporosis and obesity treatments across inpatient and outpatient settings.

The role emphasizes advanced diabetes technology, insulin management, CGM interpretation, and multidisciplinary coordination to improve long-term outcomes for complex